New York, NY -- (SBWIRE) -- 01/23/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Synta Pharmaceuticals Corp (NASDAQ:SNTA), NovaGold Resources Inc. (USA) (NYSEMKT:NG), JA Solar Holdings Co., Ltd. (ADR) (NASDAQ:JASO), Athersys, Inc (NASDAQ:ATHX)
Synta Pharmaceuticals Corp (NASDAQ:SNTA) showed a volume of 1.90 million shares by the end of last trade whereas the average volume of the stock remained 2.38 million shares. The stock opened the session at $2.92 but then moved to $2.92. Solta Medical, Inc. designs, develops, manufactures and markets professional and consumer energy-based medical device systems for aesthetic applications. The Company's systems are cleared by the United States Food and Drug Administration (FDA) for dermatological procedures performed in the physician led,
Is SNTA a Solid Investment at These Levels? Read This Report For Details
NovaGold Resources Inc. (USA) (NYSEMKT:NG) opened the session at $3.14and closed the session at $2.97. The stock showed a negative performance of -5.11% in previous trading session. NovaGold Resources Inc. (NovaGold) is engaged in the exploration and development of mineral properties. The Company has a portfolio of mineral properties located in Alaska, the United States and British Columbia, Canada.
Has NG Found The Bottom And Ready To Gain Momentum? Find Out Here
JA Solar Holdings Co., Ltd. (ADR) (NASDAQ:JASO) opened the session at $9.78and closed the session at $9.91. The stock showed a positive performance of 1.64% in previous trading session. Traded with volume of 1.88 million shares in the prior session and the average volume of the stock remained 2.28 million shares. The beta of the stock remained 3.26. JA Solar Holdings Co., Ltd. (JA Solar) is engaged in the business of designing, developing, manufacturing and selling solar cell and solar module products. The Company is also engaged in the manufacturing and sales of solar cells.
Why Should Investors Buy JASO After The Recent Gain? Just Go Here and Find Out
Athersys, Inc (NASDAQ:ATHX) the stock decreased -0.48% and finished the session at $4.15. Traded with volume of 1.88million shares in the prior session and the average volume of the stock remained 2.25 million shares. The beta of the stock remained 0.63. Athersys Inc. is a biopharmaceutical company engaged in the field of regenerative medicine. During the year ended December 31, 2011 the Company is developing its platform product, MultiStem, a allogeneic stem cell product that has been evaluated in two completed Phase I clinical trials and as of December 31, 2011,
Will ATHX Get Buyers Even After The Recent Rally? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)